Skip to Content

Endo International PLC - Stock Quote ENDP

Rating as of

Morningstar's Endo International PLC Stock Analysis

There is no Morningstar’s Analysis data available.

Endo International PLC's Company Profile

Business Description

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States.

Simmonscourt Road, Ballsbridge, First Floor, Minerva House
Dublin 4, Ireland
T +353 12682000
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type
Employees 3,103

Endo International PLC's Related News